Pathophysiology and classification of pseudomyxoma peritonei

Area of Science:

• Oncology
• Gastroenterology
• Pathology

Background:

• Pseudomyxoma peritonei (PMP) is a rare condition with a debated definition, now recognized as a clinical entity involving mucinous ascites and peritoneal implants.
• PMP typically originates from mucinous appendiceal tumors and can involve the ovaries.

Purpose of the Study:

• To review the clinical presentation and pathophysiology of pseudomyxoma peritonei.
• To introduce and discuss the implications of a new classification system for PMP.
• To explore the relationship between tumor markers and disease outcome.

Main Methods:

• Literature review of pseudomyxoma peritonei.
• Analysis of a new consensus-based classification system for PMP.
• Correlation of clinical presentation, classification, and tumor markers with patient outcomes.

Main Results:

• A consensus classification divides PMP into low and high-grade mucinous carcinomatosis peritonei.
• This classification correlates with clinical outcomes.
• Preoperative tumor marker levels also correlate with patient prognosis.

Conclusions:

• The new PMP classification system provides prognostic information.
• Tumor markers are valuable indicators of clinical outcome in PMP.
• Future research should focus on prospective studies to identify factors for poor prognosis and guide targeted treatments.